ImaginAb’s internal research program supports our desire to accelerate targeted molecular diagnostic imaging and change the future of personalized medicine:

• Exploring additional targets to add to our clinical pipeline
• Developing new protein scaffolds to expand our options when selecting the best format for each individual antibody/target
• Expanding our toolbox of radiolabels in collaboration with our academic and commercial partners to enhance our imaging capabilities
• Generating more standardized radiolabeling platforms to include additional isotopes that are able to translate pre-clinical studies into easily implemented clinical reality
• Establishing imaging protocols that can allow for faster clinical imaging and quantitation